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Uveitis is a potentially sight-
threatening eye condition 
with an estimated prevalence 
of up to 714/100 000 in the 
developing world.[1] HIV 
impacts on the burden of uveitis, as HIV-
infected individuals have increased suscep-
tibility to ocular infections and may present 
with more severe disease.[1,2] In Uganda, infec-
tious uveitis is the most common cause (41%) 
of non-correctable visual impairment among 
HIV-infected individuals.[3] In sub-Saharan 
Africa, inclu ding countries where onchocer-
ciasis is en demic, up to 25% of all blindness 
can be attributed to uveitis.[1] Uveitis has a 
wide range of causes, with an infectious origin 
in up to 50% of cases in Africa.[1]
Diagnostic challenges  
in uveitis
Early diagnosis and subsequent initiation of 
targeted antimicrobial treatment is vitally 
important for good visual outcome in 
patients with infectious uveitis.[4-6] However, 
accurate diagnosis is challenging, especially 
in resource-poor settings and in HIV-
infected individuals.[2,3] Firstly, uveitis is 
generally clinically underdiagnosed owing 
to lack of ophthalmological expertise.[2] 
Unrecognised uveitis was reported to result 
in significant visual impairment among 
Ugandan HIV-infected individuals.[3] Visual 
impairment in these cases could possibly 
have been prevented if the condition had 
been recognised early. Secondly, if uveitis 
is diagnosed clinically, the presumed cause 
may be incorrect as the diagnosis is based 
on the patient’s history and clinical and 
ophthalmological characteristics. Clinical 
features have poor predictive value for 
diagnosing the cause of uveitis, and do 
not distinguish well between infectious and 
non-infectious origin. Moreover, in cases 
of infectious uveitis, clinical features are 
poorly predictive of the causative pathogen, 
because different pathogens may present 
with similar clinical characteristics.[4,5] Based 
on diagnostic testing in almost a quarter of 
patients presenting with uveitis in studies 
from The Netherlands and South Africa (SA), 
the initial clinical diagnosis was adjusted 
and treatment altered.[4,5] An exception 
may be uveitis caused by Mycobacterium 
tuberculosis where the patient’s history (e.g. 
recent history of pulmonary tuberculosis) 
or specific retinal findings (e.g. granuloma) 
are strongly indicative of infection by this 
organism. However, tuberculosis cannot 
always be ruled out solely on the basis 
of clinical symp toms.[7] Thirdly, empirical 
treatment of infectious uveitis is difficult 
because of the wide range of potential 
uveitogenic pathogens that require targeted 
treatment (Table 1). Finally, HIV-infected 
individuals are at an increased risk of 
specific opportunistic ocular infections (e.g. 
cytomegalovirus retinitis).[2] Manifestations 
of infectious uveitis are often atypical, 
with immunosuppression resulting in 
a lower degree of inflammation, even in 
advanced uveitis, compared with HIV-
uninfected individuals. This makes clinical 
identification of the triggering pathogen 
in HIV-infected individuals particularly 
challenging.[2]
Diagnostic analysis of 
aqueous humor
The clinical diagnosis of infectious uveitis is 
increasingly supported in Western countries 
by analysis of ocular fluid[8] obtained 
through diagnostic anterior chamber 
paracentesis and aspiration of aqueous 
humor (Fig. 1). This is a well-documented 
procedure that is routinely performed 
in other aspects of ophthalmological 
care, e.g. management of acute elevation 
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of intraocular pressure and diagnosis of 
suspected intraocular infections, metastasis 
and lymphoma.[5,6] The two key diagnostic 
tests of aqueous humor are pathogen-
specific serological examination of paired 
ocular fluid and serum samples, and 
polymerase chain reaction (PCR) testing 
of the ocular fluid sample. In serological 
examination, intraocular pathogen-speci-
fic IgG is measured and compared with 
serum IgG levels (Goldmann-Witmer 
co efficient) to differentiate between intra-
ocular production of antibody and passive 
leakage from the blood as proxy for 
infection, whereas PCR identifies pathogen-
specific nucleic acids.[9] In infectious uveitis, 
pathogen-specific nucleic acids and IgG 
production are commonly detectable at 
different times after the onset of disease. 
During the early phase, nucleic acids are 
detectable within days after the onset of 
disease, followed by detection of intraocular 
IgG levels. Whereas pathogen nucleic acids 
commonly become undetectable 2 weeks 
after the onset of disease, specific antibodies 
remain detectable for many weeks in 
aqueous humor.[9] The two assays are 
therefore complementary, and contribute 
considerably to the differential diagnosis 
of infectious uveitis.[4-6,9,10] Identification of 
the triggering pathogen was established by 
serological examination and PCR in 60% of 
HIV-infected individuals presenting with 
undefined posterior uveitis, whereas PCR 
provided a final diagnosis in 39% of cases in 
which the initial diagnosis of the causative 
pathogen was uncertain.[4,10] Furthermore, 
treatment was altered on the basis of PCR 
results in 20% of patients with posterior 
uveitis of suspected infectious origin in a 
study from the USA.[6]
Anterior chamber para­
centesis in uveitis
Anterior chamber paracentesis is a safe pro-
cedure that can be performed in a consulta-
tion room with a slit-lamp.[11,12] Three studies 
have reported on the safety of this procedure 
in diagnosing uveitis.[11-13] Only a few non-
serious complications occurred, including 
traumatic hyphaema (5 cases/1 000 proce-
dures), referring to bleeding in the anterior 
chamber that may cause blurred vision, but 
usually resolves spontaneously or is easily 
treatable with topical eyedrops (e.g. topical 
steroids); similarly, injection of air into the 
anterior chamber (4 cases/1 000 procedures) 
may cause blurred vision, but is usually self-
limiting.[11-13]
Uveitis is a serious condition resulting 
in severe visual impairment and even 
blindness if not treated promptly and 
adequately. In SA, referral from lower levels 
of healthcare to a regional ophthalmology 
unit for further management and initiation 
of (empirical) treatment is indicated. 
However, even in these units treatment 
outcomes may be poor owing to the low 
predictive value of the patient’s history and 
clinical characteristics for identifying the 
cause of the uveitis.
Anterior chamber paracentesis, aspiration 
and analysis of aqueous humor provide a 
valuable diagnostic procedure that optimises 
treatment and subsequent prognosis and 
poses a very limited risk. We believe that 
this procedure could be performed in most 
settings, because a well-trained ophthalmic 
nurse could perform anterior chamber 
paracentesis safely in situations where 
qualified ophthalmologists are not available. 
Paracentesis is easier to perform than cataract 
surgery, for which ophthalmic nurses are 
trained in African countries such as Malawi 
that lack ophthalmologists.[14] In addition to 
skills development, strengthening labora tory 
infrastructure is warranted. Validation of 
existing diagnostic assays and provision of 
other resources required to analyse aqueous 
humor for the most common uveito genic 
pathogens should be considered across SA. 
Furthermore, logistic systems such as a 
cold-sample transport chain require optimi-
sation to ensure a short turnaround time and 
maximum clinical impact of this diag nostic 
test. Providing such a diagnostic service 
Fig. 1. Photograph and schematic overview of anterior chamber paracentesis for the aspiration of 
aqueous humor.
Table 1. Clinical management of the most common pathogens in infectious uveitis
Aetiology Treatment
Viruses
HSV and VZV Topical and oral or intravenous antivirals (e.g. acyclovir), 
topical corticosteroids (e.g. prednisolone acetate eyedrops), and 
intravitreal antiviral agents (e.g. ganciclovir)
CMV Intravenous and/or intravitreal antiviral agents (e.g. ganciclovir)
Bacteria
 Mycobacterium 
tuberculosis
Routine treatment for extrapulmonary tuberculosis and topical 
steroids (e.g. prednisolone acetate eyedrops)
Treponema pallidum Intravenous antibiotic treatment (e.g. penicillin G or 
ceftriaxone)
Protozoa
Toxoplasma gondii Oral antimicrobial regimens (e.g. pyrimethamine) and systemic 
steroids (e.g. prednisolone)
Onchocerca volvulus Oral ivermectin
Note: This table serves as a general guideline for the clinical management of infectious uveitis. Management of these conditions 
may differ dependent on local guidelines and availability of drugs. 
HSV = human simplex virus; VZV = varicella zoster virus; CMV = cytomegalovirus.
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would be cost-effective, reducing unnecessary use of expensive 
antimicrobial drugs and avoiding blindness and its associated 
socioeconomic costs.[15]
Conclusion
We seek to draw attention to the so far unmet need for this 
valuable diagnostic procedure and to encourage discussion among 
health care providers regarding introduction of anterior chamber 
paracentesis in the routine work-up of patients with uveitis in SA. 
Ultimately, these efforts should result in the development of clinical 
guidelines and a training programme that includes anterior chamber 
aspiration. This would improve clinical management of uveitis and 
reduce the burden of avoidable visual impairment and blindness.
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